Ed Ridley-Day
Stock Analyst at Rothschild & Co Redburn
(2.79)
# 2,801
Out of 5,028 analysts
27
Total ratings
53.8%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Ed Ridley-Day
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Upgraded: Buy | $127 | $100.10 | +26.87% | 1 | Oct 2, 2026 | |
| DHR Danaher | Reiterated: Hold | $220 → $205 | $221.21 | -7.33% | 2 | Apr 17, 2026 | |
| MDLN Medline | Initiated Coverage: Hold | $42 | $35.80 | +17.32% | 1 | Jan 12, 2026 | |
| SYK Stryker | Initiated Coverage: Hold | $115 → $420 | $285.22 | n/a | 2 | Sep 18, 2025 | |
| ZBH Zimmer Biomet Holdings | Initiated Coverage: Buy | $123 → $130 | $91.57 | n/a | 2 | Sep 18, 2025 | |
| EPA: EL EssilorLuxottica Société anonyme | Reiterated: Hold | €240.00 | €144.50 | n/a | 1 | Apr 25, 2025 | |
| QGEN Qiagen | Downgraded: Hold | $49 | $45.79 | n/a | 1 | Apr 4, 2025 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $105 | $65.74 | n/a | 2 | Sep 3, 2024 | |
| LNTH Lantheus Holdings | Initiated Coverage: Buy | $175 | $100.19 | n/a | 1 | Sep 3, 2024 | |
| ISRG Intuitive Surgical | Upgraded: Buy | $510 | $406.48 | n/a | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 205.00 | kr 249.90 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $306.34 | n/a | 1 | Jan 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $26.92 | n/a | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $53.08 | n/a | 2 | Mar 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €68.00 | €40.25 | n/a | 2 | Oct 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.65 | n/a | 2 | Oct 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.87 | n/a | 1 | Aug 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $42.40 | n/a | 1 | Mar 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $7.41 | n/a | 1 | Mar 17, 2016 |
Abbott Laboratories
Oct 2, 2026
Upgraded: Buy
Price Target: $127
Current: $100.10
Upside: +26.87%
Danaher
Apr 17, 2026
Reiterated: Hold
Price Target: $220 → $205
Current: $221.21
Upside: -7.33%
Medline
Jan 12, 2026
Initiated Coverage: Hold
Price Target: $42
Current: $35.80
Upside: +17.32%
Stryker
Sep 18, 2025
Initiated Coverage: Hold
Price Target: $115 → $420
Current: $285.22
Upside: n/a
Zimmer Biomet Holdings
Sep 18, 2025
Initiated Coverage: Buy
Price Target: $123 → $130
Current: $91.57
Upside: n/a
EssilorLuxottica Société anonyme
Apr 25, 2025
Reiterated: Hold
Price Target: €240.00
Current: €144.50
Upside: n/a
Qiagen
Apr 4, 2025
Downgraded: Hold
Price Target: $49
Current: $45.79
Upside: n/a
GE HealthCare Technologies
Sep 3, 2024
Reiterated: Buy
Price Target: $105
Current: $65.74
Upside: n/a
Lantheus Holdings
Sep 3, 2024
Initiated Coverage: Buy
Price Target: $175
Current: $100.19
Upside: n/a
Intuitive Surgical
Aug 2, 2024
Upgraded: Buy
Price Target: $510
Current: $406.48
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: kr 205.00
Current: kr 249.90
Upside: n/a
Jan 19, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $306.34
Upside: n/a
Mar 4, 2022
Upgraded: Hold
Price Target: n/a
Current: $26.92
Upside: n/a
Mar 4, 2020
Downgraded: Sell
Price Target: n/a
Current: $53.08
Upside: n/a
Oct 23, 2019
Downgraded: Hold
Price Target: €68.00
Current: €40.25
Upside: n/a
Oct 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $22.65
Upside: n/a
Aug 1, 2019
Reiterated: Buy
Price Target: n/a
Current: $43.87
Upside: n/a
Mar 17, 2016
Initiated Coverage: Buy
Price Target: $22
Current: $42.40
Upside: n/a
Mar 17, 2016
Initiated Coverage: Buy
Price Target: $23
Current: $7.41
Upside: n/a